The effects of gonadotropin-releasing hormone agonist on androstenedione production and follicular development during controlled ovarian hyperstimulation

Journal of Assisted Reproduction and Genetics

Volumn 15, Issue 8, 1998, Pages 478-484

  Akaboshi, Kouichi ^a   Oda, Takahisa ^a   Yoshida, Joji ^a   Kohriyama, Satoshi ^a   Miyazaki, Toyohiko ^b   Yoshimura, Yasunori ^b  

^a TOKYO DENTAL COLLEGE   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Androstenedione; Controlled ovarian hyperstimulation; Follicular atresia; Gonadotropin releasing hormone agonist; In vitro fertilization

Indexed keywords

ANDROSTENEDIONE; BUSERELIN; BUSERELIN ACETATE; CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; GONADORELIN AGONIST; GONATROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; NIDATION; OOCYTE MATURATION; OUTCOMES RESEARCH; OVARY FOLLICLE DEVELOPMENT; OVARY HYPERSTIMULATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ADULT; ANDROSTENEDIONE; BUSERELIN; EMBRYO TRANSFER; ESTRADIOL; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; FOLLICULAR ATRESIA; GONADOTROPINS; HUMANS; INFERTILITY, FEMALE; LUTEINIZING HORMONE; MALE; OVARIAN FOLLICLE; PREGNANCY; PROGESTERONE; PROSPECTIVE STUDIES;

EID: 0031706314     PISSN: 10580468     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022530420110     Document Type: Article

References (24)

1. Palermo R, Amodeo G, Navot D, Rosenwaks Z, Cittadini E: Concomitant gonadotropin-releasing hormone agonist and menotropin treatment for the synchronized induction of multiple follicles. Fertil Steril 1988;49:290-295
2. Neveu S, Hedon B, Bringer J, Chinchole J, Arnal F, Humeau C, Cristol P, Viala J: Ovarian stimulation by a combination of a gonadotropin-releasing hormone agonist and gonadotropins for in vitro fertilization. Fertil Steril 1987;47:639-643
3. Chetkowski RJ, Kruse LR, Nass TE: Improved pregnancy outcome with the addition of leuprolide acetate to gonadotropins for in vitro fertilization. Fertil Steril 1989;52:250-255
4. Droesch K, Muasher SJ, Brzyski RG, Jones GS, Simonetti S, Liu H, Rosenwaks Z: Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization. Fertil Steril 1989;51:292-297
5. Fleming R, Coutts JRT: Induction of multiple follicular growth in normally menstruating women with endogenous gonadotropin suppression. Fertil Steril 1986;45:226-230
6. Lejeune B, Deguelder M, Camus M, Vekemans M, Opsomer L, Leroy F: In vitro fertilization and embryo transfer as related to endogenous luteinizing hormone rise or human chorionic gonadotropin administration. Fertil Steril 1986;45:377-383
7. Silverberg KM, Burns WN, Olive DL, Riehl RM, Schenken RS: Serum progesterone levels predict success of in vitro fertilization/embryo transfer in patients stimulated with leuprolide acetate and human menopausal gonadotropins. J Clin Endocrinol Metab 1991;73:797-803
8. Hofmann GE, Bentzien F, Bergh PA, Garrisi GJ, Williams MC, Guzman I, Navot D: Premature luteinization in controlled ovarian hyperstimulation has no adverse effect on oocyte and embryo quality. Fertil Steril 1993;60:675-679
9. Yovel I, Yaron Y, Amit A, Peyser MR, David MP, Kogosowski A, Lessing JB: High progesterone levels adversely affect embryo quality and pregnancy rates in in vitro fertilization and oocyte donation programs. Fertil Steril 1995;64:128-131
10. Billig H, Furuta I, Hsueh AJW: Estrogens inhibit and androgens enhance ovarian granulosa cell apoptosis. Endocrinology 1993;133:2204-2212
11. Billig H, Furuta I, Hsueh AJW: Gonadotropin-releasing hormone directly induces apoptotic cell death in the rat ovary: biochemical and in situ detection of deoxyribonucleic acid fragmentation in granulosa cells. Endocrinology 1994;134:245-252
12. McNatty KP, Smith DM, Makris A, Osathanondh R, Ryan KJ: The microenvironment of the human antral follicle: interrelationships among the steroid levels in antral fluid, the population of granulosa cells, and the status of the oocyte in vivo and in vitro. J Clin Endocrinol Metab 1979;49:851-860
13. Kobayashi T, Oda T, Yoshimura Y, Takehara Y, Natori M, Nozawa S: Androstenedione and progesterone concentrations in preovulatory follicular fluid correlate with successful fertilization and cleavage of human oocytes in vitro. Fertil Steril 1991;56:301-305
14. Brailly S, Gougeon A, Milgrom E, Bomsel-Helmerich O, Papiernik E: Androgens and progestins in the human ovarian follicle: differences in the evolution of preovulatory, healthy nonovulatory, and atretic follicles. J Clin Endocrinol Metab 1981;53:128-134
15. Oda T, Yoshimura Y, Izumi Y, Yoshimura S, Hara T, Takehara Y, Nakamura Y, Ohno T: The effect of the follicular fluid adenosine 3′ 5′-monophosphate degradation rate on successful fertilization and cleavage of human oocytes. J Clin Endocrinol Metab 1990;71:116-121
16. Judd HL, Yen SSC: Serum androstenedione and testosterone levels during the menstrual cycle. J Clin Endocrinol Metab 1973;36:475-481
17. Abraham GE: Ovarian and adrenal contribution to peripheral androgens during the menstrual cycle. J Clin Endocrinol Metab 1974;39:340-346
18. Tureck RW, Mastroianni L Jr, Blasco L, Strauss JF III: Inhibition of human granulosa cell progesterone secretion by a gonadotropin-releasing hormone agonist. J Clin Endocrinol Metab 1982;54:1078-1080
19. Bussenot I, Azoulay-Barjonet C, Parinaud J: Modulation of the steroidogenesis of cultured human granulosa-lutein cells by gonadotropin-releasing hormone analogs. J Clin Endocrinol Metab 1993;76:1376-1379
20. Loumaye E, Coen G, Pampfer S, Vankrieken L, Thomas K: Use of a gonadotropin-releasing hormone agonist during ovarian stimulation leads to significant concentrations of peptide in follicular fluids. Fertil Steril 1989;52:256-263
21. Latouche J, Crumeyrolle-Arias M, Jordan D, Kopp N, Augendre-Ferrante, Cedard L, Haour F: GnRH receptors in human granulosa cells: Anatomical localization and characterization by autoradiographic study. Endocrinology 1989;125:1739-1741
22. Meldrum DR, Tsao Z, Monroe SE, Braunstein CD, Sladek J, Lu JKH, Vale W, Rivier J, Judd HL, Chang RJ: Stimulation of LH fragments with reduced bioactivity following GnRH agonist administration in women. J Clin Endocrinol Metab 1984;58:755-757
23. Cedars MI, Surey E, Hamilton F, Lapolt P, Meldrum DR: Leuprolide acetate lowers circulating bioactive luteinizing hormone and testosterone concentrations during ovarian stimulation for oocyte retrieval. Fertil Steril 1990;53:627-631
24. Rose GL, Dowsett M, Mudge JE, White JO, Jeffcoate SL: The inhibitory effects of danazol, danazol metabolites, gestrinone, and testosterone on the growth of human endometrial cells in vitro. Fertil Steril 1988;49:224-228